Kors v. Carey

158 A.2d 136
CourtCourt of Chancery of Delaware
DecidedFebruary 18, 1960
StatusPublished
Cited by48 cases

This text of 158 A.2d 136 (Kors v. Carey) is published on Counsel Stack Legal Research, covering Court of Chancery of Delaware primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Kors v. Carey, 158 A.2d 136 (Del. Ct. App. 1960).

Opinion

158 A.2d 136 (1960)

Bertha KORS, Plaintiff,
v.
Paul CAREY, James M. Boohecker, Chandler Cudlipp, David M. Freudenthal, James W. Newman, Edward Plaut, Walter N. Plaut, Walter E. Sachs, B. A. Tompkins, United Whelan Corporation and Lehn & Fink Products Corporation, Defendants.

Court of Chancery of Delaware, New Castle.

February 18, 1960.

*137 William E. Taylor, Jr., Wilmington, and Louis Kipnis, New York City, for plaintiff.

Robert H. Richards, Jr., of Richards, Layton & Finger, Wilmington, and Patterson, Belknap & Webb, New York City, for defendant, Lehn & Fink Products Corp., and the individual defendants.

Berl, Potter & Anderson, Wilmington, and William M. Kaplan, New York City, for defendant, United Whelan Corp.

MARVEL, Vice Chancellor.

The complaint herein as amended not only charges the directors of Lehn & Fink Products Corporation with the allegedly improper act of using corporate rather than personal funds for the purchase of 60,200 shares of Lehn & Fink stock from United Whelan Corporation as well as the separate corporate act of purchasing the assets of National Laboratories, Inc. at an excessive price, but also complains of collusive dealings between representatives of these two corporations in negotiating and consummating the stock purchase under attack. However, plaintiff conceded at trial that she would be unable to sustain her charge of collusion and further agreed to the dismissal of her cause of action concerning the purchase of the assets of National Laboratories, Inc. Thus, plaintiff's case at trial was confined to efforts to establish that the action of the Lehn & Fink directors in negotiating and consummating the purchase with corporate funds of 60,200 shares of their corporation's stock was legally improper. United Whelan, having in the meantime not only answered but cross-claimed, remains in the case as an active litigant seeking affirmative relief on its cross-claims. On a first cross-claim based on an allegation of fraud it seeks rescission of the stock sale to Lehn & Fink together with damages. It takes the position that a second cross-claim based on an alleged partial failure of consideration for the controversial purchase and sale of Lehn & Fink stock should be stayed pending disposal *138 of plaintiff's New York suit for damages brought under § 16(b)[1] of the Securities Exchange Act of 1934, and in a third cross-claim it seeks damages from the individual defendants for their alleged breaches of fiduciary duty in concealing the identity of their corporation as the actual purchaser of the 60,200 Lehn & Fink shares held by United Whelan.

The transaction which plaintiff attacks and which the seller seeks to rescind resulted from a contract consummated in February 1958 in which Lehn & Fink's identity was not disclosed. The contract provided for the purchase and sale of 60,200 shares of Lehn & Fink at $28 per share. The other basic financial facts about the transaction are as follows. On February 3, 1958, the date of the contract, Lehn & Fink stock was selling in small lots on the New York Stock Exchange at $25½ per share, and at $26¼ per share on the date of consummation of the sale. A brokerage fee of fifty cents was paid on each share so acquired. Since the purchase complained of the shares in question have been retained by the corporation as treasury stock. In recent months issued shares of stock of Lehn & Fink have been traded on the New York State Exchange at prices ranging from $45 per share to $48 per share.

Plaintiff contends that the Lehn & Fink purchase of its own shares was not only not made for a proper corporate purpose but was improperly consummated at an unreasonable price per share approximately 10% in excess of the market in a transaction which involved the spending of allegedly excessive amounts for a brokerage commission, legal fees and other outlays connected with the decision to eliminate the threat to management posed by United Whelan's ownership of a substantial block of Lehn & Fink stock. In order to consummate the purchase moneys were borrowed, but at the same time the number of issued shares outstanding was reduced and dividend requirements curtailed. However, as plaintiff points out, as a result of the transaction Edward Plaut's position as a large stockholder of Lehn & Fink (at present he holds 66,621 shares) was substantially enhanced percentagewise.

Plaintiff seeks an accounting for the loss allegedly caused the corporation as a result of the purchase complained of, and while also praying for an order requiring the corporation to sell the stock in question, did not either at trial or in her briefs picture such ultimate relief as immediately desirable.

Lehn & Fink Products Corporation is an established manufacturer of cosmetics and household drugs. It makes a number of popular cosmetics under the trade names of Dorothy Gray and Tussy as well as a disinfectant known as Lysol, which products are distributed by independent retail drug stores and drug store chains to which Lehn & Fink makes direct sales. One of Lehn & Fink's principal outlets is the fashionable firm of Lord & Taylor.

As of March 16, 1956, United Whelan had acquired 5,800 shares of the capital stock of its supplier, Lehn & Fink. By December 1956 United's holdings had risen to 20,100 registered shares together with a substantial block held in street names. Record holdings by United of such stock continued to rise to a total of 45,600 shares by March 1, 1957, at which point concern of Lehn & Fink's management about such holdings had increased to the point that in the absence from the country of Lehn & Fink's president, Edward Plaut, David M. Freudenthal, a director, conferred with United's president, Charles Green, who indicated that United's fixed policy was to eschew ordinary retail cosmetics business methods for the more immediately remunerative one of *139 dealing with manufacturers on special terms, thus reasserting a controversial business policy[2] which had been aimed at but resisted by Lehn & Fink in the past. No demand was made by Green for board membership or the like, however, no form of working agreement between Lehn & Fink and its supplier was reached, and meanwhile United continued to accumulate Lehn & Fink stock until at the end of 1957 it held 60,200 shares or approximately 16% of the 400,000 shares of issued and outstanding stock of such corporation.

United Whelan, a substantial customer of Lehn & Fink's, operates a large chain of drug stores, many of its newer ones being operated on a self-service basis. The chairman of its board and its largest stockholder, Charles Green, has waged a number of proxy fights against the managements of a variety of business enterprises, in several of which, including a 1951 one for control of United Whelan, he had been successful. While his purpose in causing United Whelan to buy Lehn & Fink stock was not fully disclosed to United's stockholders until enough of the former's stock had been accumulated to cloak United's bid for power with authority, his actual purpose in buying heavily into Lehn & Fink, namely to gain control, was conceded by Mr. Green at trial.[3]

Free access — add to your briefcase to read the full text and ask questions with AI

Related

In re P3 Health Group Holdings, LLC
Court of Chancery of Delaware, 2022
In re Wayport, Inc. Litigation
76 A.3d 296 (Court of Chancery of Delaware, 2013)
eBay Domestic Holdings, Inc. v. Newmark
16 A.3d 1 (Court of Chancery of Delaware, 2010)
Alta Health Strategies, Inc. v. Kennedy
790 F. Supp. 1085 (D. Utah, 1992)
Newell Co. v. Vermont American Corp.
725 F. Supp. 351 (N.D. Illinois, 1989)
Caballero v. Anselmo
720 F. Supp. 1088 (S.D. New York, 1989)
Mills Acquisition Co. v. MacMillan, Inc.
559 A.2d 1261 (Supreme Court of Delaware, 1989)
Blasius Industries, Inc. v. Atlas Corp.
564 A.2d 651 (Court of Chancery of Delaware, 1988)
Grobow v. Perot
539 A.2d 180 (Supreme Court of Delaware, 1988)
Grobow v. Perot
526 A.2d 914 (Court of Chancery of Delaware, 1987)
Revlon, Inc. v. MacAndrews & Forbes Holdings, Inc.
506 A.2d 173 (Supreme Court of Delaware, 1986)
Polk v. Good
507 A.2d 531 (Supreme Court of Delaware, 1986)
Unocal Corp. v. Mesa Petroleum Co.
493 A.2d 946 (Supreme Court of Delaware, 1985)
Aronson v. Lewis
473 A.2d 805 (Supreme Court of Delaware, 1984)
Wied v. Valhi, Inc.
466 A.2d 9 (Supreme Court of Delaware, 1983)
Crane Co. v. Harsco Corp.
511 F. Supp. 294 (D. Delaware, 1981)
Treadway Companies, Inc. v. Care Corp.
638 F.2d 357 (Second Circuit, 1980)
American General Insurance v. Equitable General Corp.
493 F. Supp. 721 (E.D. Virginia, 1980)

Cite This Page — Counsel Stack

Bluebook (online)
158 A.2d 136, Counsel Stack Legal Research, https://law.counselstack.com/opinion/kors-v-carey-delch-1960.